STAT5 as a molecular regulator of proliferation, differentiation and apoptosis in hematopoietic cells
暂无分享,去创建一个
A. Mui | T. Kitamura | K. Ikuta | T. Nosaka | T. Kawashima | K. Misawa
[1] R. Jove,et al. Constitutive activation of the JAK2/STAT5 signal transduction pathway correlates with growth factor independence of megakaryocytic leukemic cell lines. , 1999, Blood.
[2] J. Ihle,et al. Stat5 is required for IL-2-induced cell cycle progression of peripheral T cells. , 1999, Immunity.
[3] C. Janeway,et al. STAT5 interaction with the T cell receptor complex and stimulation of T cell proliferation. , 1999, Science.
[4] R. Eisenman,et al. Pim-1 kinase and p100 cooperate to enhance c-Myb activity. , 1998, Molecular cell.
[5] M. McMahon,et al. Identification and Characterization of a Constitutively Active STAT5 Mutant That Promotes Cell Proliferation , 2022 .
[6] Michael P. Brown,et al. Stat5a and Stat5b Proteins Have Essential and Nonessential, or Redundant, Roles in Cytokine Responses , 1998, Cell.
[7] R. Schreiber,et al. Disruption of the Jak1 Gene Demonstrates Obligatory and Nonredundant Roles of the Jaks in Cytokine-Induced Biologic Responses , 1998, Cell.
[8] A. Cumano,et al. Jak2 Deficiency Defines an EssentialDevelopmental Checkpoint in DefinitiveHematopoiesis , 1998, Cell.
[9] J. Marine,et al. Jak2 Is Essential for Signaling through a Variety of Cytokine Receptors , 1998, Cell.
[10] A. van der Eb,et al. X-ray-induced lymphomagenesis in E mu-pim-1 transgenic mice: an investigation of the co-operating molecular events. , 1998, Carcinogenesis.
[11] W. Alexander,et al. Twenty proteins containing a C-terminal SOCS box form five structural classes. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[12] A. Kraft,et al. Enforced expression of the Mr 33,000 Pim-1 kinase enhances factor-independent survival and inhibits apoptosis in murine myeloid cells. , 1997, Cancer research.
[13] R Berger,et al. A TEL-JAK2 fusion protein with constitutive kinase activity in human leukemia. , 1997, Science.
[14] W. Leonard,et al. An indirect effect of Stat5a in IL-2-induced proliferation: a critical role for Stat5a in IL-2-mediated IL-2 receptor alpha chain induction. , 1997, Immunity.
[15] H. Sakamoto,et al. Cloning and characterization of novel CIS family genes. , 1997, Biochemical and biophysical research communications.
[16] P. Marynen,et al. Fusion of TEL, the ETS-variant gene 6 (ETV6), to the receptor-associated kinase JAK2 as a result of t(9;12) in a lymphoid and t(9;15;12) in a myeloid leukemia. , 1997, Blood.
[17] R. Flavell,et al. Activation of the STAT signaling pathway can cause expression of caspase 1 and apoptosis , 1997, Molecular and cellular biology.
[18] E. Lees,et al. Raf-induced proliferation or cell cycle arrest is determined by the level of Raf activity with arrest mediated by p21Cip1 , 1997, Molecular and cellular biology.
[19] R. Snell,et al. Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[20] J. O’Shea. Jaks, STATs, cytokine signal transduction, and immunoregulation: are we there yet? , 1997, Immunity.
[21] S. Akira,et al. Structure and function of a new STAT-induced STAT inhibitor , 1997, Nature.
[22] Takaho A. Endo,et al. A new protein containing an SH2 domain that inhibits JAK kinases , 1997, Nature.
[23] Warren S. Alexander,et al. A family of cytokine-inducible inhibitors of signalling , 1997, Nature.
[24] Y. Matsuzawa,et al. Thrombopoietin-induced differentiation of a human megakaryoblastic leukemia cell line, CMK, involves transcriptional activation of p21(WAF1/Cip1) by STAT5 , 1997, Molecular and cellular biology.
[25] S. Akira,et al. Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[26] S. Lowe,et al. Oncogenic ras Provokes Premature Cell Senescence Associated with Accumulation of p53 and p16INK4a , 1997, Cell.
[27] L. Hennighausen,et al. Stat5a is mandatory for adult mammary gland development and lactogenesis. , 1997, Genes & development.
[28] J. Ihle,et al. Naturally occurring dominant negative variants of Stat5 , 1996, Molecular and cellular biology.
[29] F. Staal,et al. Use of bicistronic retroviral vectors encoding the LacZ gene together with a gene of interest: a method to select producer cells and follow transduced target cells. , 1996, Cancer gene therapy.
[30] K. Kinzler,et al. Genetic determinants of p53-induced apoptosis and growth arrest. , 1996, Genes & development.
[31] V. Gouilleux-Gruart,et al. Constitutive activation of STAT proteins in primary lymphoid and myeloid leukemia cells and in Epstein-Barr virus (EBV)-related lymphoma cell lines. , 1996, Blood.
[32] M. Kaplan,et al. Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice , 1996, Nature.
[33] P. Doherty,et al. Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells , 1996, Nature.
[34] A. Miyajima,et al. Suppression of interleukin‐3‐induced gene expression by a C‐terminal truncated Stat5: role of Stat5 in proliferation. , 1996, The EMBO journal.
[35] W. Paul,et al. Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted State6 gene , 1996, Nature.
[36] S. Akira,et al. Essential role of Stat6 in IL-4 signalling , 1996, Nature.
[37] J. Ihle,et al. Erythropoietin induces activation of Stat5 through association with specific tyrosines on the receptor that are not required for a mitogenic response , 1996, Molecular and cellular biology.
[38] M. Kaplan,et al. Stat6 is required for mediating responses to IL-4 and for development of Th2 cells. , 1996, Immunity.
[39] N. Copeland,et al. Mouse oncostatin M: an immediate early gene induced by multiple cytokines through the JAK‐STAT5 pathway. , 1996, The EMBO journal.
[40] J. Griffin,et al. Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines transformed by Bcr/Abl , 1996, The Journal of experimental medicine.
[41] J. Ihle. STATs: Signal Transducers and Activators of Transcription , 1996, Cell.
[42] R. Schreiber,et al. Targeted Disruption of the Stat1 Gene in Mice Reveals Unexpected Physiologic Specificity in the JAK–STAT Signaling Pathway , 1996, Cell.
[43] G. Nolan,et al. Applications of retrovirus-mediated expression cloning. , 1996, Experimental hematology.
[44] B. Groner,et al. STAT-related transcription factors are constitutively activated in peripheral blood cells from acute leukemia patients. , 1996, Blood.
[45] H. Nakauchi,et al. Developmental defects of lymphoid cells in Jak3 kinase-deficient mice. , 1995, Immunity.
[46] P. Doherty,et al. Defective Lymphoid Development in Mice Lacking Jak3 , 1995, Science.
[47] A. Sharpe,et al. Defects in B Lymphocyte Maturation and T Lymphocyte Activation in Mice Lacking Jak3 , 1995, Science.
[48] J. Krosl,et al. Tyrosine 343 in the erythropoietin receptor positively regulates erythropoietin‐induced cell proliferation and Stat5 activation. , 1995, The EMBO journal.
[49] J. Ihle. Cytokine receptor signalling , 1995, Nature.
[50] G. Nolan,et al. Efficient screening of retroviral cDNA expression libraries. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[51] W. Leonard,et al. Constitutively activated Jak-STAT pathway in T cells transformed with HTLV-I. , 1995, Science.
[52] B. Groner,et al. Activation of Stat5 by interleukin 2 requires a carboxyl-terminal region of the interleukin 2 receptor beta chain but is not essential for the proliferative signal transmission. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[53] N. Copeland,et al. A novel cytokine‐inducible gene CIS encodes an SH2‐containing protein that binds to tyrosine‐phosphorylated interleukin 3 and erythropoietin receptors. , 1995, The EMBO journal.
[54] R. Perlmutter,et al. Three distinct IL-2 signaling pathways mediated by bcl-2, c-myc, and lck cooperate in hematopoietic cell proliferation , 1995, Cell.
[55] P. Kluin,et al. Differentiation of follicular lymphoma cells after autologous bone marrow transplantation and haematopoietic growth factor treatment , 1995, The Lancet.
[56] H. Fujii. Activation of Stat5 by interleukin 2 requires a carboxy-terminal region β chain but is not exxential for the proliferative signal transdution. , 1995 .
[57] T. Behrens,et al. Cloning and molecular characterization of mouse bcl-x in B and T lymphocytes. , 1994, Journal of immunology.
[58] N. Davidson,et al. Epidermal growth factor-mediated apoptosis of MDA-MB-468 human breast cancer cells. , 1994, Cancer research.
[59] J. Darnell,et al. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. , 1994, Science.
[60] F. Behm,et al. Interleukin-4 induces programmed cell death (apoptosis) in cases of high-risk acute lymphoblastic leukemia. , 1994, Blood.
[61] F. Cabanillas,et al. Growth inhibition of follicular small-cleaved-cell lymphoma cells in short-term culture by interleukin-3. , 1994, Annals of oncology : official journal of the European Society for Medical Oncology.
[62] J. Trent,et al. WAF1, a potential mediator of p53 tumor suppression , 1993, Cell.
[63] S. Elledge,et al. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases , 1993, Cell.
[64] C. Thompson,et al. bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death , 1993, Cell.
[65] G. Nolan,et al. Production of high-titer helper-free retroviruses by transient transfection. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[66] T. Honjo,et al. Induced expression of PD‐1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death. , 1992, The EMBO journal.
[67] Gerard I. Evan,et al. Induction of apoptosis in fibroblasts by c-myc protein , 1992, Cell.
[68] M. Lenardo. lnterleukin-2 programs mouse αβ T lymphocytes for apoptosis , 1991, Nature.
[69] K. Miyazono,et al. Establishment and characterization of a unique human cell line that proliferates dependently on GM‐CSF, IL‐3, or erythropoietin , 1989, Journal of cellular physiology.
[70] M. Lohuizen,et al. Very high frequency of lymphoma induction by a chemical carcinogen in pim-1 transgenic mice , 1989, Nature.
[71] A. Berns,et al. Predisposition to lymphomagenesis in pim-1 transgenic mice: Cooperation with c-myc and N-myc in murine leukemia virus-induced tumors , 1989, Cell.
[72] Jos Domen,et al. The primary structure of the putative oncogene pim-1 shows extensive homology with protein kinases , 1986, Cell.
[73] G. Gill,et al. Increased phosphotyrosine content and inhibition of proliferation in EGF-treated A431 cells , 1981, Nature.